0001493152-23-000417.txt : 20230104
0001493152-23-000417.hdr.sgml : 20230104
20230104204949
ACCESSION NUMBER: 0001493152-23-000417
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230103
FILED AS OF DATE: 20230104
DATE AS OF CHANGE: 20230104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KUMAR AMIT
CENTRAL INDEX KEY: 0001191905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37492
FILM NUMBER: 23509466
MAIL ADDRESS:
STREET 1: C/O ACACIA RESEARCH CORPORATION
STREET 2: 500 NEWPORT CENTER DRIVE, 7TH FLOOR
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anixa Biosciences Inc
CENTRAL INDEX KEY: 0000715446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112622630
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
BUSINESS PHONE: 408-708-9808
MAIL ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
FORMER COMPANY:
FORMER CONFORMED NAME: ITUS Corp
DATE OF NAME CHANGE: 20140902
FORMER COMPANY:
FORMER CONFORMED NAME: COPYTELE INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2023-01-03
0
0000715446
Anixa Biosciences Inc
ANIX
0001191905
KUMAR AMIT
C/O ANIXA BIOSCIENCES, INC.
3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE,
CA
95118
1
1
0
0
Chief Executive Officer
Employee Stock Option (Right to Buy)
4.19
2023-01-03
4
A
0
700000
0
A
2033-01-03
Common Stock
700000
700000
D
Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2023.
/s/ Amit Kumar
2023-01-04